| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |